HeartBeam Price to Book Ratio 2020-2024 | BEAT
Historical price to book ratio values for HeartBeam (BEAT) over the last 10 years. The current price to book ratio for HeartBeam as of May 14, 2025 is 27.57.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| HeartBeam Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-05-14 | 1.60 | 26.10 | |
| 2024-12-31 | 2.30 | $0.06 | 37.52 |
| 2024-09-30 | 2.32 | $0.18 | 12.85 |
| 2024-06-30 | 2.57 | $0.33 | 7.84 |
| 2024-03-31 | 2.18 | $0.48 | 4.58 |
| 2023-12-31 | 2.35 | $0.61 | 3.88 |
| 2023-09-30 | 2.15 | $0.71 | 3.04 |
| 2023-06-30 | 2.41 | $0.81 | 2.97 |
| 2023-03-31 | 2.27 | $-0.10 | -21.74 |
| 2022-12-31 | 4.88 | $0.30 | 16.46 |
| 2022-09-30 | 3.90 | $0.72 | 5.44 |
| 2022-06-30 | 1.29 | $1.12 | 1.15 |
| 2022-03-31 | 1.84 | $1.54 | 1.20 |
| 2021-12-31 | 3.08 | $1.72 | 1.79 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.058B | $0.000B |
| HeartBeam Inc. is a development stage digital healthcare company with proprietary ECG telemedicine technology. HeartBeam Inc. is based in SANTA CLARA, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $39.242B | 54.20 |
| Hims & Hers Health (HIMS) | United States | $14.325B | 148.84 |
| Tempus AI (TEM) | United States | $11.867B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.712B | 73.62 |
| IRhythm Technologies (IRTC) | United States | $4.463B | 0.00 |
| Privia Health (PRVA) | United States | $2.963B | 202.50 |
| Enovis (ENOV) | United States | $2.134B | 11.90 |
| Clover Health Investments (CLOV) | United States | $1.737B | 0.00 |
| Schrodinger (SDGR) | United States | $1.735B | 0.00 |
| Phreesia (PHR) | United States | $1.534B | 0.00 |
| Omnicell (OMCL) | United States | $1.312B | 23.14 |
| Azenta (AZTA) | United States | $1.277B | 59.36 |
| 10x Genomics (TXG) | United States | $1.180B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.618B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.589B | 0.00 |
| Talkspace (TALK) | United States | $0.514B | 153.50 |
| Veradigm (MDRX) | United States | $0.455B | 0.00 |
| Standard BioTools (LAB) | United States | $0.433B | 0.00 |
| Claritev (CTEV) | United States | $0.405B | 0.00 |
| TruBridge (TBRG) | United States | $0.375B | 831.67 |
| Health Catalyst (HCAT) | United States | $0.299B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.208B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.197B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.156B | 0.00 |
| Pulmonx (LUNG) | United States | $0.133B | 0.00 |
| American Well (AMWL) | United States | $0.119B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.084B | 0.00 |
| CareCloud (CCLD) | United States | $0.084B | 3.19 |
| Retrieve Medical Holdings (RMHI) | United States | $0.083B | 0.00 |
| 111 (YI) | China | $0.068B | 0.00 |
| Outset Medical (OM) | United States | $0.062B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.059B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.030B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.018B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.011B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |